TODD STRATEGY GROUP

Lobbying for TAKEDA PHARMACEUTICALS AMERICA, INC. · Pharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · $50,000.00 income · posted Oct 20, 2025

Lobbying activity 2

Health Issues

Rare Disease Issues.

Medicare/Medicaid

General Medicare/Medicaid Issues. Implementation of Inflation Reduction Act of 2022.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.